Navigation Links
Receptos to Deliver Scientific Presentation at Digestive Disease Week 2012 about the Therapeutic Role of RPC1063 in Inflammatory Bowel Disease
Date:5/18/2012

SAN DIEGO, May 18, 2012 /PRNewswire/ -- Receptos Inc. today announced that company personnel will deliver a scientific podium presentation about RPC1063 at the Digestive Disease Week (DDW) annual meeting at 9 a.m. PDT on Sunday, May 20, 2012 at the San Diego Convention Center in San Diego, California. DDW attracts thousands of physicians, researchers, and academics from around the world to share the latest research in gastrointestinal health topics, for which DDW is the premier scientific conference. Based on an abstract entitled "A small molecule S1P1 receptor agonist with significant efficacy in animal models of inflammatory bowel disease (IBD)," Receptos scientific personnel will discuss positive preclinical data with RPC1063 in two distinct in vivo models of IBD.

"Based on exciting data from these preclinical studies, as well as data from a recently completed Phase 1 clinical safety study, Receptos will initiate a Phase 2 clinical trial with RPC1063 in 2012 in inflammatory bowel disease," said Faheem Hasnain, President and Chief Executive Officer of Receptos. "The acceptance of these preclinical efficacy data for presentation at DDW underscores the need for efficacious oral treatments for the therapeutic treatment of IBD and the excitement on the part of scientific and clinical investigators to explore the novel profile of RPC1063 in patients suffering from this debilitating disease."

About RPC1063 and S1P1 Agonists
RPC1063 is a novel, differentiated sphingosine 1-phosphate 1 receptor (S1P1) selective agonist exhibiting picomolar potency that is effective in rodent models of both multiple sclerosis (MS) and inflammatory bowel disease (IBD), and possesses an excellent safety profile in non-clinical toxicology studies. Receptos has completed a Phase 1 clinical safety study with RPC1063 under a US IND that supports the desired differentiation profile and establishes justification for initiation of MS and IBD clinical efficacy
'/>"/>

SOURCE Receptos Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Receptos Achieves Milestone Under License of G-Protein Coupled Receptor Crystal Structure Determination Technology
2. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
3. AXIOS™ Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
4. Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
5. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
6. Sustained Growth Forecast for Medical Devices and Drug Delivery Markets According to New Market Research Available from Global Information Inc.
7. VICAMs New Fumo-V Strip Tests Delivers Accurate Detection of Fumonisin Mycotoxins in Minutes
8. FDA Clears Expanded Compatibility for INOMAX® Drug-Delivery Systems
9. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Annual Report
10. Medical Device Study Delivers Marketing Budget and Staffing Metrics to Promote Efficient Use of Resources
11. Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... -- Tom Daulton, CEO of Mammotome, a division of Devicor Medical ... Cincinnati chapter of the Association for ... top executive who is also a breast cancer survivor, led ... March of 2010. Daulton will be presented with the award ... Bank, on May 22. The ACG Deal Maker ...
(Date:5/21/2013)... May 21, 2013 Kepner-Tregoe (KT), the ... that 13-year veteran Chris Geraghty ... experience includes more than 20 years serving the ... manufacturing organizations. He succeeds Ray Baxter ... Kepner-Tregoe,s Chairman of the Board and CEO. ...
(Date:5/21/2013)... 2013  Armada Health Care (Armada) is pleased ... corporate website ( www.armadahealthcare.com ).  This new website ... first-to-market services and its position as the leading ... pharmacy industry. The updated website visibly ... model in delivering an extensive portfolio of services ...
Breaking Medicine Technology:Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2
... Toll-Like Receptor 3 (TLR3) Agonist, SAN DIEGO, ... announced that the company has developed a,proprietary vaccine ... for use in both therapeutic and prophylactic vaccines., ... a Toll-like Receptor 3 (TLR3) agonist that when ...
... N.C., June 18 Pilot Therapeutics,Holdings, Inc. ... as Gene,Smart(TM) Health., (Logo: http://www.newscom.com/cgi-bin/prnh/20080618/CLW006LOGO ... gene-based nutrition, Gene Smart(TM) Health uniquely,combines breakthrough ... health, food, nutrition, and wellness markets to ...
Cached Medicine Technology:Nventa Develops Proprietary Vaccine Adjuvant 2Nventa Develops Proprietary Vaccine Adjuvant 3Nventa Develops Proprietary Vaccine Adjuvant 4Pilot Therapeutics Announces Relaunch as Gene Smart(TM) Health 2
(Date:5/21/2013)... 21, 2013 Phoseon Technology will present ... the 20th Annual IMI European Ink Jet Conference ... leader, Phoseon continues to invest in product development to ... of UV LED curing in printing applications. Phoseon ... the market offering both air cooled and water cooled ...
(Date:5/21/2013)... Modern couples have countless strains ... Counseling’s Sexuality and Relationship Workshops, couples are learning ... healthier habits for their relationship. There are both ... and individuals at Texas Counseling. Their goal is ... skills to develop long term solutions. , ...
(Date:5/21/2013)... of Defense Serum Repository (DoDSR), University of Cincinnati (UC) ... bowel disease (IBD), which could help with earlier diagnosis ... symptoms. , This finding, the first of its kind ... presented via podium presentation by staff from Walter Reed ... being held May 18-21 in Orlando, Fla. , ...
(Date:5/21/2013)... The Las Vegas personal injury law firm Benson, ... Gates, a senior at Coronado High School, is the winner ... . As the winner of the essay contest, Crawford received ... Dec. 1, 2012 and ran through April 30th, 2013. Participating ... minimum essay on “The Role of the civil tort system.” ...
(Date:5/21/2013)... A new study appearing in the current issue ... harvested from fat (adipose) are more potent than those ... body’s immune system. , The finding could have ... tissue-derived stem cells (AT-SCs) are far more plentiful in ... can be collected from waste material from liposuction procedures. ...
Breaking Medicine News(10 mins):Health News:Workshops Offered To Identify Underlying Challenges That Put Strain On Relationships 2Health News:Biomarkers discovered for inflammatory bowel disease 2Health News:Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 2Health News:Stem Cells from Fat Outperform Those from Bone Marrow in Fighting Disease 3
... PARK, Md., June 5 Dynasplint Systems, Inc. --, ... 34th annual,Severna Park Independence Day Parade and Festival. Held ... at St. Martin,s -in-the-field and,Our Shepherd Lutheran churches on ... and family activities at Cypress Creek Park., This ...
... Predicts Growing Opposition on Capitol Hill Once Negative Impact ... June 5 In thanking U.S.,Senators Kent Conrad (D-ND), ... (D-ND) and Shelley Moore Capito (R-WV) for leading a,new ... plan to,cut by regulatory means $770 million in seniors, ...
... Ind., June 5 Hill-Rom (NYSE: HRC ... Award for the,TotalCare(R) Bariatric Plus therapy system. The ... This is the second year in a row,that ... award., The TotalCare Bariatric Plus therapy system ...
... also provides business update, including fourth-quarter fiscal 2008 ... ... Iowa, June 5 Meredith Corporation,(NYSE: MDP ), one of ... Communications, a leading healthcare,marketing communications firm. Additionally, the company provided a,business ...
... to reject unfair offer, study shows , , THURSDAY, June 5 ... serotonin govern the way people react to unfair offers when ... , Serotonin, which carries messages between neurons, is involved in ... anger in women was affected by variations in a gene ...
... apparently solved a long-standing frustration in creating certain synthetic molecules ... with fewer side effects. , Like human hands, many molecules ... left. But usually only one of the two versions has ... sometimes even harmful. For example, side effects from the morning ...
Cached Medicine News:Health News:Front Line Caregiver Coalition Thanks Sens. Conrad, Coleman and Reps. Pomeroy, Capito and Berkley for Leading Bipartisan Hill Effort to Stop Bush Administration's Damaging Medicare Cuts 2Health News:Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award 2Health News:Hill-Rom Innovative TotalCare(R) Bariatric Plus Therapy System Receives Gold Medical Device Excellence Award 3Health News:Meredith Expands Integrated Marketing Capabilities by Acquiring Top Healthcare Marketing Communications Firm 2Health News:Meredith Expands Integrated Marketing Capabilities by Acquiring Top Healthcare Marketing Communications Firm 3Health News:Meredith Expands Integrated Marketing Capabilities by Acquiring Top Healthcare Marketing Communications Firm 4Health News:Meredith Expands Integrated Marketing Capabilities by Acquiring Top Healthcare Marketing Communications Firm 5Health News:Serotonin Levels Determine Sense of Fairness 2Health News:Duke chemist has new way to tell right from left 2
...
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 35G x 5/8in (.50 x 16mm)...
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 25G x 5/8in (.50 x 16mm)...
... Unique product designed for LASIK surgery ... Designed to irrigate the corneal interface ... easy insertion under the flap and ... ports provide multi-directional irrigation.27G x 7/8in ...
Medicine Products: